IL-20 antagonist suppresses PD-L1 expression and prolongs survival in pancreatic cancer models

Journal: Nature Communications

Published: 2020-09-14

DOI: 10.1038/s41467-020-18244-8

Affiliations: 7

Authors: 7

Go to article
Institutions Share
Institute of Basic Medical Sciences, NCKU, Taiwan 0.21
Department of Biochemistry and Molecular Biology, NCKU, Taiwan 0.21
Institute of Clinical Medicine, NCKU, Taiwan 0.14
National Cheng Kung University Hospital, Taiwan 0.14
Institute of Molecular Medicine, NCKU, Taiwan 0.14
Institute for Translational Research in Biomedicine (ITRBM), Chang Gung Medical Foundation, Taiwan 0.14

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER